Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Product News
Gyros Launches Nanoliter-scale Immunoassay System
Tuesday, February 10, 2015
Gyrolab xPlore - A more compact, cost-effective, single-CD tool at SLAS2015 Conference.

BioGenes Establishes Distribution Network for Generic HCP Assay in Major Markets
Wednesday, February 04, 2015
Company has signed long-term agreements with distributors in USA and Canada, India, Japan and Middle/South America.

ProImmune Introduces ProM2™ Human Class II MHC Monomer Reagents
Friday, January 30, 2015
Enabling proven tetramer analysis for detecting single antigen-specific T cells.

Bringing Customers a New Web Experience - Alfa Aesar Launches Redesigned Website
Thursday, January 29, 2015
The redesign provides a fresh new layout and offers improved intuitive navigation with a high degree of user-friendliness.

Irvine Scientific Introduces PRIME-XV® T Cell Culture Medium
Wednesday, January 21, 2015
A xeno-free and serum-free medium for immunotherapy applications.

Specificity-Verified Monoclonal Antibodies
Friday, January 16, 2015
Ultraspecific and extensively validated monoclonal antibodies from AMSBIO.

Ebola Antigens and Antibodies for ELISA
Friday, December 19, 2014
AMSBIO products for the development of an ELISA detection assay for the Ebola virus.

Imperial Innovations Leads £50 Million Series B Funding Round in Cell Medica
Tuesday, November 25, 2014
Cell Medica will use the investment capital to progress further the development of cellular immunotherapy products.

Merck Millipore Launches Kit for Analyzing NF?B Translocation
Thursday, November 20, 2014
Permits quantitative, statistically robust assessment of NF?B translocation.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 385
Scientific News
Starting Antiretroviral Treatment Early Improves Outcomes for HIV-infected Individuals
NIH-funded trial results likely will impact global treatment guidelines.
Viral Immunotherapy For Skin Cancer Shows Patient Benefit
A genetically engineered herpes virus can halt the progression of skin cancer by killing cancer cells and sparking the immune system into action against tumours, a landmark clinical trial has shown.
How Hep C Survives Immune System Attacks
Using mathematical modelling researchers have uncovered the tactics employed by the Hep C in order to avoid the immune system.
Baylor, TGen Collaborate on Personalized Cancer Treatment Options
The companies will collaborate on precision medicine for cancer patients by offering liquid biopsies, performing gene sequencing, conducting clinical trials, and creating personalized vaccines.
Freshly Squeezed Vaccines
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines.
New Target for Treating Rheumatoid Arthritis
Many affected individuals still suffer with progressive joint damage, despite treatment. This study has discovered a new treatment target which could open a door to preventing this ongoing damage.
Shining A New Light On The Immune System
Scientists at the University of St Andrews have developed a revolutionary method of identifying cells of the immune system with “molecular fingerprints” which could pave the way for the rapid detection of conditions such as leukaemia and lymphoma from a small blood sample.
Promising Malaria and Dengue Vaccines Will Not Defeat Diseases
Although vaccination is a key part of the control of disease GlobalData stress the importance of a multi-dimensional approach.
'Redesigned' Antibodies May Neutralize HIV
With the help of a new computer program researchers have made structural alterations to an antibody, increasing its ability to tackle the AIDS virus.
How Early Childhood Vaccination Reduces Leukemia Risk
Chronic infections push ‘pre-leukemia’ cells, common in newborns, into malignancy.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters